SOLV

SOLVENTUM CORP-W/I

SOLV·83444M101·US·Common Stock·Healthcare - Medical Instruments & Supplies-13D/G

SOLV (SOLVENTUM CORP-W/I) is held by 255 institutional investors as of Q2 2026. Largest holders: Independent Franchise Partners LLP ($1.2B), BlackRock, Inc. ($753.1M), VANGUARD CAPITAL MANAGEMENT LLC ($742.6M). Net institutional sentiment: Mixed. In Q2 2026, 2 members of Congress and 125 funds bought SOLV.

255
Holders
(22 Elite)
$8.3B
Total Value
45% (275)
Consensus
125 buying - 150 selling
13F: Insider & Congress: Updated regularly
SOLV

Smart Money Verdict

View all
Loading verdict
Held by 255 funds
22 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders May 1, 2026 · Activists Apr 30, 2026 · Congress Aug 5, 2026

InsiderACALBAN CARLOSExercise 3K shApr 30, 2026
InsiderWHWEILAND JOHN HExercise 3K shApr 30, 2026
ActivistVAVanguard Capital Management6.3%Apr 30, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
16.2M(+2.8%)$1.2B8.2%+22.84%
65
Decreased
9.8M(-6.8%)$753.1M0.0%+37.33%
0
Increased
9.6M(+0.2%)$742.6M0.0%+29.23%
32
Decreased
6.3M(-1.0%)$488.3M0.0%+29.26%
0
Decreased
6.3M(-0.4%)$486.7M2.1%+59.41%
0
Decreased
5.6M(-12.0%)$435.1M0.0%+67.82%
0
Increased
4.9M(+3.3%)$378.3M0.0%+30.83%
32
Increased
4M(+3.2%)$311.5M0.3%+28.34%
38
Decreased
3.3M(-12.7%)$255.4M0.0%+54.98%
0
Increased
2.1M(+11.2%)$160.4M0.0%+29.63%
34
Unchanged
2.1M$159.6M0.1%+73.09%
0
Decreased
1.9M(-19.6%)$150.1M1.2%+20.21%
0
Increased
1.8M(+134.6%)$140.2M0.0%+31.13%
49
Decreased
1.5M(-13.0%)$118.3M0.0%+56.16%
0
Increased
1.5M(+0.2%)$117.5M0.0%+57.21%
30
Decreased
1.4M(-9.9%)$107.1M0.0%+61.30%
0
Decreased
1.3M(-9.8%)$99.7M0.0%+27.87%
0
Increased
1.2M(+122.1%)$92.6M0.0%+20.32%
48
Increased
1.1M(+48.2%)$83.5M0.0%+28.84%
41
Increased
956,447(+16.5%)$73.8M0.0%+26.73%
34

Showing 1-20 of 284

1 / 15
SOLVSOLVSOLVENTUM CORP-W/I

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used